Piebanga LW, Laibson PR. Dendritic lesions in herpes zoster ophthalmicus. Arch Ophthalmol. 1973;90:268.CrossRef

Miserocchi E, Waheed NK, Dios E, et al. Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison. Ophthalmology. 2002;109:1532–7.PubMedCrossRef

de Boer JH, Luyendijk L, Rothova A, Kijlstra A. Analysis of ocular fluids for local antibody production in uveitis. Br J Ophthalmol. 1995;79:610–6.PubMedCentralPubMedCrossRef

Matos K, Muccioli C, Belfort Junior R, Rizzo LV. Correlation between clinical diagnosis and PCR analysis of serum, aqueous, and vitreous samples in patients with inflammatory eye disease. Arq Bras Oftalmol. 2007;70(1):109–14.PubMedCrossRef

Siverio Júnior CD, Imai Y, Cunningham Jr ET. Diagnosis and management of herpetic anterior uveitis. Int Ophthalmol Clin. 2002;42:43–8.PubMedCrossRef

Colin J, Prisant O, Cochener B, et al. Comparison of the efficacy and safety of valacyclovir and acyclovir for the treatment of herpes zoster ophthalmicus. Ophthalmology. 2000;107:1507–11.PubMedCrossRef

Tyring S, Engst R, Corriveau C, Robillard N, Trottier S, Van Slycken S, Crann RA, Locke LA, Saltzman R, Palestine AG. Famciclovir for ophthalmic zoster: a randomised aciclovir controlled study. Br J Ophthalmol. 2001;85(5):576–81.PubMedCentralPubMedCrossRef

Rodriguez A, Power WJ, Neves RA, et al. Recurrence rate of herpetic uveitis in patients on long-term oral acyclovir. Doc Ophthalmol. 1995;90:331–40.PubMedCrossRef

Cobo ML, Foulks GN, Liesegang T, et al. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology. 1986;93:763–70.PubMedCrossRef

Parrish CM. Herpes simplex virus eye disease. In: Focal points: clinical modules for ophthalmologists, vol. 101. San Fancisco: American Academy of Ophthalmology; 1997. p. 1871–82.

Wilhelmus KR, Falcon MG, Jones BR. Herpetic iridocyclitis. Int Ophthalmol. 1981;4:143–50.CrossRef

Tabbara KF, Al Balushi N. Topical ganciclovir in the treatment of acute herpetic keratitis. Clin Ophthalmol. 2010;4:905–12.PubMedCentralPubMedCrossRef

Wong A, Tan KH, Tee CS, Yeo GS. Seroprevalence of cytomegalovirus, toxoplasma and parvovirus in pregnancy. Singapore Med J. 2000;41(4):151–5.PubMed

Gratacap-Cavallier B, Bosson JL, Morand P, et al. Cytomegalovirus seroprevalence in French pregnant women: parity and place of birth as major predictive factors. Eur J Epidemiol. 1998;14(2):147–52.PubMedCrossRef

Hwang YS, Shen CR, Chang SH, Lai CC, Liu CL, Chen KJ, Lin KK, Chen TL, Hsiao CH. The validity of clinical feature profiles for cytomegaloviral anterior segment infection. Graefes Arch Clin Exp Ophthalmol. 2011;249(1):103–10.PubMedCrossRef